Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13946505 | 1.00 | CYP2C19 (0.50) | CYP2C19CYP1A2CYP2C9CHRM3KCNN4 | |
| SCHEMBL6481604 | 1.00 | CYP2C19 (0.50) | CYP2C19CYP1A2CYP2C9CHRM3KCNN4 | |
| Sulfuric Acid SCHEMBL15206344 | 0.90 | CYP2C19 (0.42) | CYP2C19CYP1A2CYP2C9CHRM3KCNN4 | |
| SCHEMBL4307361 | 0.88 | CYP2C19 (0.56) | CYP2C19CYP1A2CYP2C9CHRM3KCNN4 | |
| SCHEMBL7943831 | 0.85 | CYP2C19 (0.58) | CYP2C19CYP1A2CYP2C9KCNN4KDM4E | |
| SCHEMBL11331380 | 0.83 | CYP2C19 (0.47) | CYP2C19CYP1A2CYP2C9CHRM3KCNN4 | |
| SCHEMBL28639570 | 0.83 | CYP2C19 (0.47) | CYP2C19CYP1A2CYP2C9CHRM3KCNN4 | |
| SCHEMBL23014014 | 0.80 | CYP2C19 (0.48) | CYP2C19CYP1A2CYP2C9CHRM3KCNN4 | |
| SCHEMBL1292634 | 0.80 | TAAR1 (0.50) | CYP2C19CYP1A2CYP2C9CHRM3KCNN4 | |
| SCHEMBL29703352 | 0.79 | ESR2 (0.44) | CYP2C19CYP1A2CYP2C9CHRM3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108704492-A | A kind of preparation method of porous silicon carbide ceramic membrane | 台州利欧环保新材料有限公司 | 2018-10-26 | — | — | CN | claimed |
| CN-108658604-A | A kind of preparation method of porous silicon carbide flat ceramic supporter | 台州利欧环保新材料有限公司 | 2018-10-16 | — | — | CN | claimed |
| CN-107267667-A | DNA/RNA virus PCR real time enhancings reaction kit, detection reagent and its application method | 成都海之元生物科技有限公司 | 2017-10-20 | — | — | CN | claimed |
| CN-101062861-A | Photon energy ceramic powder and preparation method thereof | QUE SHANCAI (CN) | 2007-10-31 | — | — | CN | claimed |
| CN-108704492-A | A kind of preparation method of porous silicon carbide ceramic membrane | 台州利欧环保新材料有限公司 | 2018-10-26 | — | — | CN | disclosed |
| CN-108658604-A | A kind of preparation method of porous silicon carbide flat ceramic supporter | 台州利欧环保新材料有限公司 | 2018-10-16 | — | — | CN | disclosed |
| CN-105591150-A | Nonaqueous electrolyte solution, rechargeable battery, micro-hybrid battery, and battery system | A123 SYSTEMS LLC | 2016-05-18 | — | — | CN | disclosed |
| CN-105591149-A | Rechargeable battery and electrolyte composition thereof | A123 SYSTEMS LLC | 2016-05-18 | — | — | CN | disclosed |
| CN-101062861-A | Photon energy ceramic powder and preparation method thereof | QUE SHANCAI (CN) | 2007-10-31 | — | — | CN | disclosed |
| CN-1329326-C | Dielectric material and dielectric material sintered body and wiring board using such ceramic | NGK SPARK PLUG CO (JP) | 2007-08-01 | — | — | CN | disclosed |
| WO-2005003140-A1 | 4-OXO-4,7-DIHYDROTHIENO[2,3-B]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2005-01-13 | — | — | WO | disclosed |
| US-20050004161-A1 | 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents | AGOURON PHARMACEUTICALS, INC. | 2005-01-06 | — | — | US | disclosed |
| US-4204010-A | Radiation curable, ethylenically unsaturated thixotropic agent and method of preparation | W. R. GRACE & CO. (US) | 1980-05-20 | — | — | US | disclosed |
| US-4137389-A | Low-molecular weight acrylate resins and a process for their production | BAYER AKTIENGESELLSCHAFT (DE) | 1979-01-30 | — | — | US | disclosed |
| US-4031290-A | ALPHA-BETA MONOMERS, CATALYSIS | PPG INDUSTRIES, INC. (US) | 1977-06-21 | — | — | US | disclosed |
| US-4025474-A | AUTOMOTIVE FINISHING | PPG INDUSTRIES, INC. (US) | 1977-05-24 | — | — | US | disclosed |
| US-4016332-A | OF ETHYLENICALLY UNSATURATED MONOMERS | PPG INDUSTRIES, INC. (US) | 1977-04-05 | — | — | US | disclosed |
| US-3994851-A | AMINE-ALDEHYDE CROSSLINKING AGENT | PPG INDUSTRIES, INC. (US) | 1976-11-30 | — | — | US | disclosed |
| US-3954440-A | Substituted 2-hydroxy-2-phenylbutylsulfonate compounds | THE DOW CHEMICAL COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
| US-3933940-A | Mercaptan blocked thermosetting copolymers | PPG INDUSTRIES, INC. (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004161-A1 | 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents | ZC3HAV1, IRF3, BRD4 | CYP2C19 2078/4885CYP1A2 1382/4885CYP2C9 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.